<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Cancer":8,
"Consanguinity":1,
"Druze":1,
"Incidence rates":1,
"Israel":2,
"Smoking":1,
"Filipino":1,
"Quality of life":1,
"Validation":1,
"carcinoma":1,
"follicular":1,
"metastatic":1,
"oral":1,
"thyroid":13,
"Adenocarcinomas":1,
"ETV6-NTRK3":1,
"Mammary analog secretory carcinoma":1,
"Salivary gland-type carcinomas":1,
"CD56":2,
"Synaptophysin":1,
"Thyroid paraganglioma":1,
"Thyroidectomy":8,
"graves":1,
"hematoma":2,
"malignancy":2,
"toxic nodular goitre":1,
"Cervical sympathetic trunk":1,
"Deep lobe of parotid gland":1,
"External carotid artery":1,
"First bite syndrome":1,
"Parapharyngeal space":1,
"Anaplastic thyroid carcinoma (ATC)":1,
"Anaplastic transformation":1,
"Papillary thyroid carcinoma (PTC)":3,
"Pleural metastasis":1,
"Carcinoma, papillary/pathology":1,
"Follow-up studies":2,
"Incidence":2,
"Neck dissection":2,
"Prognosis":9,
"Thyroglossal cyst/epidemiology":1,
"Thyroglossal cyst/pathology":1,
"Thyroglossal cyst/surgery":1,
"Thyroid neoplasms/pathology":1,
"131-I":1,
"Differentiated Thyroid cancer":8,
"SPECT/CT":1,
"Staging":1,
"Whole body scan":1,
"Risk classification":1,
"Thyroid cancer":29,
"Thyroid neoplasm":2,
"Thyroid nodule":7,
"Ultrasound":5,
"DIAGNOSTICS":1,
"LABORATORY TESTS":1,
"MOLECULAR ONCOLOGY":1,
"head neck cancer":1,
"radiation-induced hypothyroidism":1,
"Fukushima Daiichi nuclear power plant accident":1,
"health survey":1,
"physician training":1,
"pre-distribution":1,
"stable iodine administration":1,
"Adjuvant RAI":1,
"Lymphadenectomy":2,
"Follicular adenoma":2,
"Hashimoto’s thyroiditis":2,
"Molecular markers":3,
"Epidemiology":4,
"RAI":2,
"Screening":2,
"Surgery":6,
"IMRT":1,
"NPC":1,
"MV-CBCT":1,
"secondary cancers":1,
"Radiation therapy":2,
"Survivorship":1,
"Brazil":1,
"cervical cancer":1,
"low–intermediate income countries":1,
"mortality":2,
"trends":1,
"Hypothyroidism":2,
"Postoperative concurrent chemoradiotherapy":1,
"TSH":1,
"Thyroid function after radiotherapy":1,
"Total laryngectomy":1,
"Total pharyngo-laryngo-esophagectomy":1,
"Adjuvant chemotherapy":1,
"Capecitabine":1,
"Colon cancer":1,
"Feasibility study":1,
"Japanese":1,
"X-ACT trial":1,
"metabolic disorders":1,
"prevalence":1,
"serum uric acid":1,
"BRAF K601E":1,
"BRAF mutation":1,
"thyroid pathology":1,
"Attention":1,
"Breast neoplasms":1,
"Chemotherapy":4,
"Cognition":1,
"Compensatory cognitive training":1,
"Memory":1,
"diagnostic performance":1,
"shear wave elastography (SWE)":1,
"thyroid imaging reporting and data system (TI-RADS)":1,
"thyroid nodules":6,
"“tandem” and “parallel”":1,
"Adult":2,
"BRAF":2,
"Mutation":2,
"Papillary thyroid carcinoma":19,
"Pediatric":1,
"TERT":2,
"apatinib":1,
"maximum standard uptake value":1,
"radioiodine refractory differentiated thyroid cancer":1,
"safety":2,
"thyroglobulin":2,
"Bax":1,
"Caspase-3":1,
"Caspase-9":1,
"Dimethylbenz(a)anthracene":1,
"Survivin":1,
"Graves’ disease":1,
"cytological alteration":1,
"histologic changes":1,
"radioactive iodine treatment":1,
"Distant metastasis":2,
"Lymph node metastasis":4,
"Papillary thyroid cancer":3,
"Predictor":1,
"Survival":1,
"adrenal gland":1,
"autofluorescence":1,
"indocyanine green":1,
"parathyroid gland":1,
"thyroid gland":1,
"Multivariate analysis":1,
"PCA":1,
"TI-RADS":1,
"Ultrasonography":3,
"Apoptosis induction":1,
"Cancer cells":1,
"Cidofovir":1,
"Mesothelioma":1,
"Thyroid carcinoma":11,
"Cytokine":1,
"Inflammatory disease":1,
"Interleukin-32 (IL-32)":1,
"Spliced isoforms":1,
"Therapeutic approaches":1,
"Chemotherapy and chemoradiotherapy":1,
"Circulating tumor cells":1,
"Liquid biopsy":1,
"Pancreatic cancer":1,
"The CellSearch system":1,
"Ambient mass spectrometry":1,
"Cancer staging":1,
"Lipid profiles":1,
"Mass spectrometry imaging":1,
"Metastatic cancer":1,
"MASC":1,
"cytology":2,
"Apoptosis":3,
"BRAF(V600E) inhibitor":1,
"Bcl2 family protein":1,
"Orthotopic model":1,
"FNA":1,
"PET-positive":1,
"incidental nodules":1,
"Asia Cohort Consortium":1,
"Asians":1,
"Cancer mortality":1,
"Meta-analysis":6,
"Type 2 diabetes":2,
"accuracy":1,
"touch imprint cytology":1,
"Follicular variant of papillary thyroid carcinoma":2,
"NIFTP":1,
"131I therapy":1,
"mathematical modeling":1,
"radiation protection":1,
"radiation safety":1,
"radiopharmaceutical therapy":1,
"Fine needle cytology":1,
"Thyroid surgery":2,
"Growth inhibition":1,
"Invasion":3,
"Migration":1,
"Telomerase":2,
"siRNA":1,
"children and adolescents":1,
"differentiated thyroid carcinoma":3,
"postoperative thyroglobulin":1,
"prognostic factors":2,
"Long-term survival":1,
"Mitosis":1,
"Tumor necrosis":1,
"EML4-ALK":1,
"PAX8-PPARgamma":1,
"RAS":3,
"TFG-MET":1,
"clear-cell thyroid carcinoma":1,
"follicular thyroid carcinoma":3,
"BRAFV600E mutation":1,
"genetic alterations":2,
"racial disparities":1,
"temporal trends":1,
"The Bethesda System":1,
"cytomorphology":1,
"fine-needle aspiration":2,
"noninvasive encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC)":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"Clonal relationship":1,
"Multifocal papillary thyroid carcinoma":1,
"Multifocality":1,
"Whole genome sequencing":2,
"Allele-specific PCR":1,
"Allele-specific copy number":1,
"cancer evolution":1,
"metastatic colorectal carcinoma":1,
"mutational analysis":1,
"phylogenetic tree":1,
"synchronous metastases":1,
"Diagnosis":2,
"Metastasis":5,
"Computer-assisted interventions":1,
"Electromagnetic tracking":1,
"Thyroid radiofrequency ablation":1,
"Ultrasound guidance":1,
"encapsulated follicular variant of papillary thyroid carcinoma":1,
"fine needle aspiration cytology":1,
"invasive follicular variant of papillary thyroid carcinoma":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"thyroid ultrasound":2,
"SIRs":1,
"second primary malignancy":1,
"Adolescents":1,
"CT":1,
"Children":2,
"Incidentaloma":1,
"Papillary carcinoma":2,
"TNM staging":2,
"delayed risk stratification":1,
"extrathyroidal invasion":1,
"neoplasm invasion":1,
"risk factors":3,
"NTRK3":1,
"RET":3,
"fusion gene":1,
"oncogene":2,
"rearrangement":1,
"TSH receptor":1,
"targeted therapy":4,
"theranostics":1,
"Follicular variant":2,
"Continental Population Groups":1,
"Thyroid Neoplasms":12,
"columnar cell variant":1,
"differential diagnosis":1,
"fine-needle aspiration (FNA)":2,
"Thyroglobulin measurement":1,
"Thyroglobulin stability":1,
"Thyroid nodes":1,
"Washout of fine needle aspiration biopsies":1,
"CBX7":1,
"DKK1":1,
"glioma":1,
"wnt/β-catenin pathway":1,
"mathematical model":1,
"metastatic thyroid cancer":1,
"personalized medicine":1,
"radioactive iodine therapy":1,
"therapeutic nuclear medicine":1,
"Diabetes mellitus":1,
"Obesity":1,
"Sedentary lifestyle":1,
"adrenocortical cancer":1,
"molecular genetics":1,
"paraganglioma":2,
"parathyroid carcinoma":1,
"phaeochromocytoma":1,
"pituitary carcinoma":1,
"tyrosine kinase inhibitor":2,
"China":1,
"prospective study":1,
"radioiodine":2,
"remnant ablation":1,
"thyroid TIRADS":1,
"thyroid guidelines":1,
"FATS":1,
"biomarker":2,
"breast cancer":6,
"radiotherapy":3,
"genetics":1,
"hereditary tumors":2,
"Surgical management":1,
"Thyroid lobectomy":1,
"Total thyroidectomy":2,
"131I":2,
"low-grade mucoepidermoid tumor":1,
"parotid":1,
"Endocrine tumor":1,
"Medullary thyroid cancer":2,
"Central neck dissection":2,
"Prophylactic central neck dissection":3,
"Airway":1,
"Locally invasive":1,
"Multimodality":1,
"Clusterin":1,
"Endocrine tumors":1,
"Immunohistochemistry":8,
"Medullary thyroid carcinoma":2,
"Neuroendocrine tumors":1,
"Thyroid tumors":1,
"PEBP4":1,
"PI3K/Akt pathway":2,
"Proliferation":2,
"risk":1,
"fine needle aspiration":1,
"gene expression profiling":1,
"molecular testing":1,
"CCR2 antagonist":1,
"MMP-9":1,
"motility and invasion":1,
"non-small cell lung cancer":1,
"viability":1,
"Case-control studies":1,
"Hormone replacement therapy":1,
"Oral contraceptives":1,
"Reproductive history":1,
"100&nbsp":1,
"mSv threshold":1,
"Ethics":1,
"Fukushima nuclear power plant accident":1,
"Linear no-threshold":1,
"Risk communication":1,
"NRAS":1,
"Q61R":1,
"colorectal carcinoma":1,
"Acoustic radiation force impulse":1,
"Contrast-enhanced ultrasound":1,
"Shear wave elastography imaging":1,
"Gastric cancer":1,
"SLC2A1":1,
"glycolysis":1,
"microRNA-148b":1,
"canalicular adenoma":1,
"intra-operative frozen section diagnosis":1,
"intra-tumoral hematoma":1,
"papillary thyroid carcinoma-like histology":1,
"striated duct adenoma":1,
"Capsular invasion":1,
"Capsule":1,
"pregnancy":2,
"tumor growth":1,
"Pheochromocytoma":1,
"Primary hyperparathyroidism":1,
"complications":1,
"hypocalcemia":1,
"outcomes":1,
"Percentage difference":1,
"Tumor size":1,
"Ultrasonography diameter":1,
"human papillomavirus":1,
"lung":1,
"mixed squamous and glandular papilloma":1,
"p16Ink4a":1,
"Right para-oesophageal lymph node (RPELN)":1,
"HSP90 inhibitor":1,
"ganetespib":1,
"Gene fusion":1,
"Indeterminate cytology":1,
"Cowden syndrome":1,
"PTEN":2,
"PTEN hamartoma tumor syndrome":1,
"Central lymph node metastasis":2,
"Curage cervical central prophylactique":1,
"Microcarcinome papillaire thyroïdien":1,
"Papillary thyroid microcarcinoma":3,
"Risk stratification":1,
"Stadification TNM":1,
"Stratification du risque":1,
"venous thromboembolism":1,
"CYP1A2":1,
"Dioxin receptor":1,
"Receptors cross-talk":1,
"S14":1,
"Triiodothyronine":2,
"anaplastic thyroid cancer":1,
"doxorubicin":1,
"drug delivery":1,
"extracorporeal shock waves":1,
"nanobubbles":1,
"anaplastic thyroid carcinoma":3,
"next generation sequencing":1,
"growth differentiation factor 15":1,
"MDM2-p53 interaction":1,
"anti-tumor":1,
"dedifferentiated thyroid cancer":1,
"ABO blood type":1,
"Young breast cancer":1,
"And thyroid cancer":1,
"DNA repair":1,
"Genetic instability":1,
"Homologous recombinant repair":1,
"Over expression":1,
"Proliferation marker":1,
"GAS5":1,
"Long non-coding RNA":1,
"Survival analysis":1,
"BRAFV600E":1,
"endocrine":1,
"Nasopharyngeal carcinoma":1,
"Rac1":1,
"WxxxE motif":1,
"anti-cancer polypeptide":1,
"azurin protein":1,
"ALA":1,
"DHLA":1,
"PTP1B":1,
"SHP2":1,
"lipoic acid":1,
"follicular thyroid adenoma":1,
"follicular thyroid cancer":1,
"gene expression":1,
"microarray":1,
"IFNγ":1,
"cytokine signaling":1,
"phosphatidylserine":1,
"quantitative biology":1,
"transcriptional regulation":1,
"tumor inflammation":1,
"tumor microenvironment":1,
"Endocrine cancer":1,
"Head and neck cancer":1,
"Head and neck surgery":1,
"Pathology":1,
"Thyroid disease":2,
"Recurrent laryngeal nerves":1,
"Variation":1,
"Vocal cord paralysis":1,
"Boron":1,
"Cadmium":1,
"Heavy metals":1,
"Metalloids":1,
"Molybdenum":1,
"Volcanic area":1,
"Sleeping Beauty":1,
"Swi/Snf":1,
"thyroid cancer genomics":1,
"18F-fluorodeoxyglucose (18F-FDG)":1,
"differentiated thyroid cancer (DTC)":1,
"positron emission tomography/computed tomography (PET/CT)":1,
"post-therapeutic 131I whole-body scan (131I-WBS)":1,
"serum thyroglobulin (Tg)":1,
"thyroid-stimulating hormone (TSH)":1,
"TT-1":1,
"Interferon-α (IFN-α)":1,
"Natural killer (NK) cells":1,
"Hepatocarcinoma":1,
"Immunotherapy":1,
"Pituitary, Adrenal, Incidentaloma":1,
"DNA methylation":1,
"Human telomerase reverse transcriptase gene":1,
"Polymorphism":2,
"Postoperative recurrence":1,
"Nodular goiter":1,
"Poorly differentiated thyroid carcinoma":1,
"RAS mutation":1,
"renal":1,
"FOLFIRINOX":1,
"lipase hypersecretion syndrome":1,
"pancreatic acinar cell carcinoma":1,
"pancreatic panniculitis":1,
"Computed tomography":1,
"Texture analysis":1,
"Texture feature":1,
"circulating biomarkers":1,
"microRNA":1,
"recurrence":4,
"Carcinoma diferenciado de tiroides":1,
"Incidencia cáncer tiroides":1,
"Microcarcinoma":1,
"Thyroid carcinoma incidence":1,
"flavonoid":1,
"invasiveness":1,
"iodide uptake":1,
"phytochemical":1,
"radioiodine therapy":3,
"sodium iodide symporter (NIS)":1,
"Afirma":1,
"The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)":1,
"ThyGenX":1,
"ThyraMIR":1,
"ThyroSeq":1,
"molecular":1,
"Reoperative central neck dissection":1,
"Video-assisted central neck dissection":1,
"Mature ovarian teratoma":1,
"healthcare delivery":1,
"DNA damage":1,
"genetic material stability":1,
"thyroid stunning":1,
"Parvovirus B19":1,
"interleukin 6":1,
"non-structural protein 1":1,
"nuclear factor kappa B":1,
"tumor necrosis factor alpha":1,
"MAPK":1,
"sorafenib":1,
"Central lymph node dissection":1,
"Prelaryngeal lymph node metastasis":1,
"Pretracheal lymph node metastasis":1,
"Lung adenocarcinoma":1,
"Non-small-cell lung cancer":1,
"Thyroid transcription factor 1":1,
"tyrosine kinase inhibitors":2,
"Lateral pelvic lymph nodes":1,
"Lower rectal cancer":1,
"Micrometastasis":1,
"Sentinel nodes":1,
"Carcinoma, papillary":5,
"Lymphatic metastasis":3,
"Pathology, clinical":2,
"Disease-free survival":1,
"Multifocal tumor":1,
"RET/ PTCrearrangement":1,
"Bisphenol A":1,
"Icarrin":1,
"Superoxide dismutase":1,
"Epithelium":1,
"Neoplasms":2,
"Pax2":1,
"Pax8":1,
"Tissue microarray":1,
"Therapy":1,
"p53":1,
"p53 inhibition mechanisms":1,
"p63":2,
"p73":1,
"target therapies":1,
"Differentiated thyroid cancers (DTC)":1,
"Local anesthesia":1,
"Gender inequality":1,
"MiR-608":1,
"rs4919510":1,
"the Cancer Genome Atlas":1,
"Adrenal disorders":1,
"Endocrinology":1,
"Psychiatry":1,
"RTK inhibitor":1,
"c-Met signalling":1,
"valproic acid":1,
"EMT":1,
"HCC":1,
"SOX12":1,
"miR-874":1,
"cell-free DNA":1,
"integrity index":1,
"plasma":1,
"qPCR":1,
"Humans":1,
"Philippines":1,
"Retrospective studies":1,
"Survival rate":1,
"Core needle biopsy":1,
"rapid on-site evaluation":1,
"completion lymphadenectomy":1,
"tall-cell variant":1,
"Adjuvant":1,
"Papillary":1,
"Trachea":1,
"Bilateral axillo-breast approach (BABA)":2,
"modified radical neck dissection (MRND)":1,
"robot":1,
"endocrine surgical procedures":1,
"robotics":1,
"ER":1,
"PR":1,
"Neoplasm metastasis":1,
"iodine radioisotopes":1,
"Medullary thyroid carcinoma (MTC)":1,
"genotype-phenotype correlation":1,
"multiple endocrine neoplasia type 2 (MEN2)":1,
"prophylactic thyroidectomy":1,
"rearranged during transfection (RET)":1,
"Calcifications":1,
"Centricity":1,
"Clinicopathological features":1,
"Tall cell variant":1,
"B-CPAP cell line":1,
"TERT mutation":1,
"thyrosphere":1,
"TSH feedback control":1,
"deiodinase":1,
"levothyroxine treatment":1,
"set point":1,
"thyroid homeostasis":1,
"Biopsy, Fine-Needle":1,
"dosimetry":1,
"metastatic disease":1,
"radio iodine":1,
"refractory thyroid cancer":1,
"doubling time":1,
"growth curves":1,
"inflection point":1,
"MEN":1,
"TKI":2,
"tyrosine kinase":1,
"RECIST":1,
"oncogenes":1,
"protein kinases":1,
"vascular endothelial growth factor":1,
"cabozantinib":1,
"vandetanib":1,
"gastrointestinal":1,
"hypertension":1,
"management":1,
"toxicity":1,
"chronic lymphocytic thyroiditis":1,
"ABI3":1,
"CYFIP1":1,
"PI3K/AKT":1,
"WAVE2":1,
"intratumoral IL-17A overexpression":1,
"solid tumor":1,
"worse outcome":1,
"evolution":1,
"genomics":1,
"mutations":1,
"selection":1,
"Cushing syndrome":1,
"neuroendocrine tumours":1,
"pancreatic neoplasms":1,
"SEER":1,
"Case report":1,
"Hyperparathyroidism":1,
"PTH":1,
"Parathyroid cyst":1,
"Parathyroid hormone":1,
"Somalia":1,
"cancer distribution":1,
"esophagus cancer":1,
"CK7":1,
"HMWK":1,
"TTF1":1,
"lung carcinoma":1,
"AMP-activated protein kinase":1,
"gene knockout":1,
"mice model":1,
"differential thyroid carcinoma":1,
"skull base":1,
"endoplasmic reticulum stress":1,
"metformin":1,
"extracellular protein kinase 2":1,
"nuclear factor erythroid-2 related factor 2":1,
"p-ERK½":1,
"D-dimer":1,
"Progression-free survival":1,
"Small-cell lung cancer":1,
"Therapeutic effect":1,
"androgen receptor":1,
"head and neck":1,
"nonsquamous cell carcinoma":1,
"preliminary study":1,
"epidemiologic research design":1,
"methods":1,
"patient participation rates":1,
"registries":1,
"research subject recruitment":1,
"surveys and questionnaires":1,
"Fine-needle aspiration biopsy-FNAB":1,
"follicular cancer":1,
"papillary cancer":1,
"scintigraphy":1,
"solitary thyroid nodule":1,
"cancer of the hypopharynx":1,
"head and neck spindle cell carcinoma":1,
"sarcomatoid carcinoma":1,
"spindle cell carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年6月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
